低氧诱导因素1α调节了间歇性肺炎介导的肺癌进展
Kiyofumi Shimoji1, Taku Nakashima2, Takeshi Masuda1
1Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Journal of translational medicine
|November 28, 2023
概括
间歇性肺炎使肺癌的预后恶化,需要新的治疗方法. 亚酸向低氧诱导因子1通路,抑制瘤生长和纤维化在这种结合条件下.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 病理生理学 病理生理学
背景情况:
- 患有间歇性肺炎的肺癌患者的预后较差.
- 肺癌与间歇性肺炎的治疗选择有限.
- 对于这种患者群体,需要一种新的治疗策略.
研究的目的:
- 研究间歇性肺炎和肺癌之间的病理生理联系.
- 探索结合肺癌和间歇性肺炎的潜在治疗剂.
主要方法:
- 建立了肺癌与间歇性肺炎的杂交小鼠模型.
- 分析了瘤进展,纤维化,RNA表达和瘤微环境.
- 检查了患有肺癌和间歇性肺炎同时发生的患者的临床数据.
主要成果:
- 在模型中观察到的加速瘤生长和瘤微环境的改变.
- 鉴定了低氧诱导因子1 (HIF-1) 信号通路的升调.
- 亚酸降低了HIF-1的调节,抑制了瘤的进展,并减少了肺纤维化.
结论:
- 低氧诱导因子1通路在患有间歇性肺炎的肺癌中至关重要.
- HIF-1 作为一个潜在的治疗目标.
- 亚斯科布酸显示为减轻间歇性肺炎介导的肺癌进展的治疗方法.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


